Shulian Wang

5.1k total citations
177 papers, 3.5k citations indexed

About

Shulian Wang is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Shulian Wang has authored 177 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Oncology, 63 papers in Pathology and Forensic Medicine and 55 papers in Surgery. Recurrent topics in Shulian Wang's work include Breast Cancer Treatment Studies (44 papers), Lymphoma Diagnosis and Treatment (36 papers) and Advanced Radiotherapy Techniques (35 papers). Shulian Wang is often cited by papers focused on Breast Cancer Treatment Studies (44 papers), Lymphoma Diagnosis and Treatment (36 papers) and Advanced Radiotherapy Techniques (35 papers). Shulian Wang collaborates with scholars based in China, United States and Singapore. Shulian Wang's co-authors include Ye‐Xiong Li, Weihu Wang, Zhongxing Liao, Susan L. Tucker, Wei Xiong, James D. Cox, Yue‐Ping Liu, Jing Jin, Zihao Yu and Hui Fang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Shulian Wang

165 papers receiving 3.5k citations

Peers

Countries citing papers authored by Shulian Wang

Since Specialization

Citations

This map shows the geographic impact of Shulian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shulian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shulian Wang more than expected).

Fields of papers citing papers by Shulian Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shulian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shulian Wang. The network helps show where Shulian Wang may publish in the future.

Co-authorship network of co-authors of Shulian Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shulian Wang. A scholar is included among the top collaborators of Shulian Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shulian Wang. Shulian Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant immunotherapy and chemoradiotherapy for mismatch repair proficient locally advanced rectal cancer: A systematic review and meta-analysis 2025 ·Radiotherapy and Oncology ·Yu Wang, (unknown), Xu Guan, Xin Liu, Yuan Tang, Wenwen Zhang, Chunxia Du, Shuangmei Zou, (unknown), (unknown), (unknown), (unknown), Shulian Wang, (unknown), Ye‐Xiong Li	0
2	Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancer 2024 ·Scientific Reports ·Shijia Wang, Yirui Zhai, Wen‐Wen Zhang, Siye Chen, (unknown), (unknown), Yu Tang, Yong-Wen Song, Yueping Liu, Bo Chen, Shunan Qi, (unknown), (unknown), Ye‐Xiong Li, Jing Hao, Shulian Wang	0
3	Optimizing the prognostic capacity of baseline 18F-FDG PET/CT metabolic parameters in extranodal natural killer/T-cell lymphoma by using relative and absolute thresholds 2024 ·Heliyon ·Yingming Zhu, (unknown), Xin Liu, Shu‐Nan Qi, Shulian Wang, Hui Fang, Yongwen Song, Yueping Liu, Jing Jin, Ning Li, Ning-Ning Lu, (unknown), Yuan Tang, Bo Chen, Wen‐Wen Zhang, Yirui Zhai, Yong Yang, Bin Liang, Rong Zheng, Ye‐Xiong Li	2
4	Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II Study 2023 ·Technology in Cancer Research & Treatment ·(unknown), (unknown), (unknown), Zhiqiang Liu, Siye Chen, Yong-Wen Song, Yu Tang, Jing Hao, (unknown), Xu-Ran Zhao, (unknown), Yue‐Ping Liu, (unknown), Shunan Qi, Ning Li, (unknown), Ning-Ning Lu, Ye‐Xiong Li, Shulian Wang	1
5	Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac 2023 ·Frontiers in Oncology ·(unknown), Yuan Tian, (unknown), (unknown), (unknown), Yong-Wen Song, Shulian Wang, (unknown), Hui Fang, (unknown), Shunan Qi, (unknown), Yue‐Ping Liu, (unknown), Bo Chen, Nianzeng Xing, Ye‐Xiong Li, (unknown)	6
6	Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting 2023 ·Cancer Medicine ·Wenyang Liu, Wen Zhang, Yuan Tang, Silin Chen, Ning Li, (unknown), Jinming Shi, Shulian Wang, Ye‐Xiong Li, (unknown), (unknown)	5
7	Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial 2022 ·Practical Radiation Oncology ·(unknown), (unknown), (unknown), Jing Hao, Na Zhang, (unknown), Yahua Zhong, (unknown), Hong-Fen Wu, (unknown), (unknown), Weifang Yang, Xiaohong Wang, Xiaorong Hou, Yufei Lu, Lina Zhao, Jing Jin, Ye‐Xiong Li, Shulian Wang	5
8	Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC 2021 ·Hepatology ·Bo Chen, Jianxiong Wu, (unknown), Liming Wang, Weiqi Rong, Fan Wu, Shulian Wang, Jing Jin, Yue‐Ping Liu, Yongwen Song, Hua Ren, Hui Fang, Yuan Tang, Ning Li, Ye‐Xiong Li, Weihu Wang	48
9	Automatic segmentation of three clinical target volumes in radiotherapy using lifelong learning 2021 ·Radiotherapy and Oncology ·Kuo Men, Xinyuan Chen, (unknown), Ji Zhu, Junlin Yi, Shulian Wang, Ye‐Xiong Li, Jianrong Dai	13
10	Non-coplanar volumetric modulated arc therapy for locoregional radiotherapy of left-sided breast cancer including internal mammary nodes 2021 ·Radiology and Oncology ·Yuan Xu, (unknown), Zhihui Hu, Yuan Tian, Kuo Men, Shulian Wang, Yingjie Xu, Jianrong Dai	7
11	Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes 2020 ·Cancer ·Yu Tang, Yujing Zhang, Na Zhang, Mei Shi, Ge Wen, Jing Cheng, Hongmei Wang, Min Liu, (unknown), (unknown), Hong-Fen Wu, (unknown), Jing Jin, Yue‐Ping Liu, Yong-Wen Song, Hui Fang, Hua Ren, Shulian Wang, Ye‐Xiong Li	11
12	Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions 2020 ·BMC Cancer ·Shulian Wang, Ge Wen, Yu Tang, Yong Yang, Jing Hao, Jianyang Wang, (unknown), Xu-Ran Zhao, (unknown), Jing Jin, Yong-Wen Song, Yue‐Ping Liu, (unknown), Yujing Zhang, Ye‐Xiong Li	12
13	Predicting the risk of non-sentinel lymph node metastasis in breast cancer patients with 1-2 positive sentinel lymph nodes 2019 ·Zhonghua fangshe zhongliuxue zazhi ·Zhou Huang, Yu Tang, Shulian Wang, Yongwen Song, Jing Jin, (unknown), (unknown), Hao Jing, Jianyang Wang, Yueping Liu, Bo Chen, Shunan Qi, Ning Li, Yuan Tang, Ning-Ning Lu	1
14	Cardiac dosimetry of deep inspiration breath-hold technique in whole breast irradiation for left breast cancer after breast-conserving surgery 2018 ·Zhonghua fangshe zhongliuxue zazhi ·Siye Chen, Shulian Wang, Yu Tang, Yuan Tian, (unknown), (unknown), Jing Jing, Yueping Liu, Yong-Wen Song, (unknown), Bo Chen, (unknown), Jianghao Zhang, (unknown), (unknown)	1
15	Comparison of concurrent chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone in stage II/III rectal cancer patients after radical operation 2014 ·Zhonghua fangshe zhongliuxue zazhi ·Yanru Feng, Jing Jin, Xin Wang, Qin Xiao, Weihu Wang, Shulian Wang, Yue‐Ping Liu	2
16	Long-term efficacy of CHOP-based chemotherapy alone or combined with radiotherapy for adolescent/childhood primary systemic anaplastic large-cell lymphoma 2014 ·Zhonghua fangshe zhongliuxue zazhi ·Hui Fang, Ximei Zhang, Jing Jin, Weihu Wang, Yong-Wen Song, Yueping Liu, Shulian Wang	0
17	The effect of oxaliplatin plus capecitabine in combination with radiation for locally advanced lower or middle sited rectal carcinoma 2014 ·Zhonghua fangshe zhongliuxue zazhi ·Qin Xiao, Jing Jin, Ye‐Xiong Li, Weihu Wang, Shulian Wang, Yueping Liu, Yongwen Song	1
18	Analysis of recurrence for locally advanced gastric or gastroesophageal cancer patients after receiving curative gastrectomy ( ＞ D1 ) and its indication for adjuvant chemoradiotherapy 2011 ·Zhonghua fangshe zhongliuxue zazhi ·Xin Wang, Jing Jin, Ye‐Xiong Li, Shulian Wang, Weihu Wang, Yong-Wen Song, Yueping Liu, Xin-Fan Liu, Zihao Yu	3
19	Outcome of locally advanced rectal cancer patients treated with radical surgery followed by concurrent capecitabine and radiotherapy 2011 ·Zhonghua fangshe zhongliuxue zazhi ·Ning-Ning Lu, Jing Jin, Ye‐Xiong Li, Shulian Wang, Weihu Wang, Yong-Wen Song, Yueping Liu, Hua Ren, Hui Fang, Shiping Zhang, Xin-Fan Liu, Zihao Yu	1
20	Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma 2009 ·Clinical Cancer Research ·Ye‐Xiong Li, (unknown), Hui Fang, Shunan Qi, Hua Wang, Weihu Wang, (unknown), Jiade J. Lu, Jing Jin, Shulian Wang, Yueping Liu, Ning Lü, Xin-Fan Liu, Zihao Yu	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact